<?xml version="1.0" encoding="UTF-8"?>
<p id="Par30">All haematological patients receiving specific treatment (including monoclonal antibodies in monotherapy) from 1 March, 2017, the date the EAS was launched, to 1 March, 2018, were included.</p>
